CAP-100
Product Specifications
Target
CCR
Related Pathways
GPCR/G Protein, Microbiology/Virology, Immunology/Inflammation
Bioactivity
CAP-100 is a monoclonal antibody targeting CCR7. It neutralizes the ligand binding site and signaling of CCR7. This compound effectively inhibits migration, extravasation, homing, and survival in chronic lymphocytic leukemia (CLL) samples induced by CCR7. CAP-100 can mediate potent tumor cell killing through host immune mechanisms and exhibits favorable toxicity profiles in related hematopoietic cell subsets. It is involved in research on antitumor activity and diseases like chronic lymphocytic leukemia (CLL) .
Shipping Conditions
Ice Packs
Storage Temperature
-20°C
Available Sizes
More Discoveries
Explore Other Products
Browse additional items from our catalog
E6615 96 Tests
Leucine-rich repeat-containing protein 58 (LRRC58) Mouse ELISA Kit
Sign In for Pricing
View Details 
125363-HRP 100 µL
CRY2 (Cryptochrome 2, Cryptochrome-2, KIAA0658) (HRP)
Sign In for Pricing
View Details